Company not implementing a reverse split at this time
Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea
Company not implementing a reverse split at this time
Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.